Skip to Main Content
Table 1

Clinical characteristics of study participants

Obese NGTT2DMP
Age (years) 41 ± 9 55 ± 9 0.006 
Sex (male/female) 3/8 8/3 0.008 
BMI (kg/m233.2 ± 1.1 32.5 ± 1.6 0.55 
HbA1c, % (mmol/mol) 5.4 ± 0.7 (36 ± 5) 7.0 ± 0.3 (53 ± 2) <0.001 
FPG (mmol/L) 5.8 ± 0.1 7.9 ± 0.7 0.001 
FPI (μU/mL) 6.5 ± 1.2 10.8 ± 1.9 0.02 
2-h PG (mmol/L) 7.0 ± 0.2 15.2 ± 1.5 <0.001 
Fasting plasma FFA (mmol/L) 0.45 ± 0.03 0.67 ± 0.08 0.01 
Obese NGTT2DMP
Age (years) 41 ± 9 55 ± 9 0.006 
Sex (male/female) 3/8 8/3 0.008 
BMI (kg/m233.2 ± 1.1 32.5 ± 1.6 0.55 
HbA1c, % (mmol/mol) 5.4 ± 0.7 (36 ± 5) 7.0 ± 0.3 (53 ± 2) <0.001 
FPG (mmol/L) 5.8 ± 0.1 7.9 ± 0.7 0.001 
FPI (μU/mL) 6.5 ± 1.2 10.8 ± 1.9 0.02 
2-h PG (mmol/L) 7.0 ± 0.2 15.2 ± 1.5 <0.001 
Fasting plasma FFA (mmol/L) 0.45 ± 0.03 0.67 ± 0.08 0.01 

Data are means ± SEM unless otherwise indicated. 2-h PG, 2-h plasma glucose during OGTT.

Close Modal

or Create an Account

Close Modal
Close Modal